Reducing MRSA on orthopaedic wards

<<< Back to main page

I am unable to understand why, after publication of the evidence I submitted on 30th July quoting the two papers on the efficacy of ascorbate in killing MRSA in Japanese research by Nakanishi T. and available on Entrez PubMed, no interest at all has been shown.

Could it not be the case that non-toxic IV ascorbate would provide an instant solution to these infections and many others, and may one ask why it has not been done? There is not even a negative paper to be found in the literature on the subject of multigram doses of ascorbate IV - only many successes and positively beneficial sequelae. The prompt resolution of many bacterial and viral infections by ascorbate IV have been reported by Klenner F and others from 1949 onwards.

If the public has to wait much longer as the death rate mounts, might not MRSA patients start discharging themselves from hospitals in order to start injecting themselves?

I would.

Sydney J Bush PhD. DOpt. (IOSc. London)

Competing interests: None.

================================
Sydney J Bush
PhD.,DOpt. (IOSc., London)
Optometrist & Contact Lens Practitioner
The Hull Contact Lens and Eye Clinic.
also... .Anti-Coronary Clinics (UK) Ltd.
Yorkshire CardioRetinometry facility.
20-22 Brook St. HULL East Yorkshire.
ENGLAND HU2 8LA
Tel 0044 (0) 1482 223131 (fax 227636)
================================

MRSA - Methicillin Resistant Staphylococcus aureus

Back to top